Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
Open Access
- 30 January 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Cell International
- Vol. 18 (1), 1-10
- https://doi.org/10.1186/s12935-018-0514-2
Abstract
P53 is a tumor suppressor and key regulator of glycolysis in cancer cells, however highly mutated in tumors. In ovarian cancer, studies concerning p53 mutations focus on the DNA binding domain since the majority of hotspot mutations affects this region. Yet, mutations in other regions such as the proline rich domain may also affect the protein’s expression and activity. The aim of this study is to investigate the effect of various positions of mutations in TP53 gene on glycolysis, apoptosis and transcription of p53 target genes. Mutations frequency and their effect on p53 expression were assessed by PCR-SSCP, sequencing and immunohistochemistry on 30 ovarian cancer biopsies. Six tumors were cultured, as well as SK-OV-3, OVCAR-3 and Igrov-1. SK-OV-3 cells were transfected with 2 TP53 mutants. p53 transcriptional activity was assayed by qPCR, apoptosis by flow cytometry and glycolysis by glucose and lactate measurements, with quantification of glycolytic enzymes expression. Our results showed a high frequency of the P72R mutant, associated with p53 overexpression in the ovarian biopsies. However, P72R mutant cells showed similar apoptosis and glycolysis as WT cells. DNA binding domain mutations decreased the transcriptional activity of the protein and increased glucose consumption and lactate production. Despite the overexpression of the P72R mutated protein in the biopsies, it showed a similar apoptotic activity and glucose regulation ability as WT p53. Knowing that p53 expression status is used for chemotherapeutic approaches and prognosis in ovarian cancer, the results obtained highlight the importance of locating TP53 mutations.Keywords
Funding Information
- Research Council of Saint Joseph University
This publication has 31 references indexed in Scilit:
- Regulation of the pentose phosphate pathway in cancerProtein & Cell, 2014
- p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexesOncogene, 2013
- The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysisNucleic Acids Research, 2012
- p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2Cancer Research, 2012
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysisLaboratory Investigation, 2011
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical UseCold Spring Harbor Perspectives in Biology, 2009
- Functions of p53 in metabolism and invasionBiochemical Society Transactions, 2009
- p53: new roles in metabolismTrends in Cell Biology, 2007
- The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene ExpressionCancer Research, 2004
- Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and BiologicallyMolecular and Cellular Biology, 1999